"Bayer AG won a second consecutive trial in California over its top-selling Roundup weedkiller as a jury rejected a woman’s claim that it caused her cancer, Jef Feeley reports for Bloomberg. "The verdict Thursday in state court in San Bernardino follows a Los Angeles jury’s Oct. 5 decision rejecting a mother’s claim that her young son developed cancer from exposure to the herbicide in the family’s yard."
The verdicts come after Bayer lost all three similar trials in California in 2018. Bayer wants the U.S. Supreme Court to throw out one of the cases on the grounds that federal herbicide regulations trump state regulations. A successful appeal "could help the company fend off thousands of Roundup suits," Feeley reports.
Bayer recently announced it will pull the current version of Roundup from the lawn and garden market in 2023, but will still sell to farmers. Its active ingredient, glyphosate, has long been controversial over reports that it can harm people, pollinators and endangered species, and can increase pesticide resistance in crops and harm crops that aren't genetically engineered to survive it.
from The Rural Blog https://ift.tt/3EVWE9m Bayer wins two Roundup cases, seeks appeal asserting that federal pesticide regulations trump state rules - Entrepreneur Generations
0 Response to "Bayer wins two Roundup cases, seeks appeal asserting that federal pesticide regulations trump state rules - Entrepreneur Generations"
Post a Comment